Hepatitis A virus clinical trials
How each study uses Hepatitis A virus is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 1
Humacyte, Inc. (4) · Washington University School of Medicine (1) · Sinovac Biotech Co., Ltd (1) · Novartis (1)
Often tested with
Tested in the same studies.
Influenza Vaccines (1) · Human papilloma virus (1) · Chickenpox Vaccine (1)
Studies
Open first, then newest update. How each study uses Hepatitis A virus is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for HemodialysisCompletedPhase 3Humacyte, Inc.NCT02644941Written as Human Acellular Vessel (HAV)
- Longitudinal Tracking of Bone Marrow Plasma Cell Responses to Licensed Human VaccinesActive, not recruitingPhase 4Washington University School of MedicineNCT07493460Written as hepatitis A (HAV) vaccines
- Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for HemodialysisCompletedPhase 3Humacyte, Inc.NCT03183245Written as Human Acellular Vessel (HAV)
- Humacyte's HAV for Femoro-Popliteal Bypass in Patients With PADCompletedPhase 2Humacyte, Inc.NCT02887859Written as Human Acellular Vessel (HAV)
- Safety and Efficacy Assessment of HAV in Patients Needing Vascular Access for DialysisCompletedPhase 2Humacyte, Inc.NCT04135417Written as HAV
- Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B VaccineCompletedPhase 4Sinovac Biotech Co., LtdNCT02445703Written as Inactivated Hepatitis A vaccine (HAV)
- Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy InfantsCompletedPhase 3NovartisNCT00806195Written as Hepatitis A Virus
Given beside what is tested · 1 — Hepatitis A virus is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Hepatitis A virus
Codes
What other systems call Hepatitis A virus · ClinicalTrials.gg INT016628
- UNII (FDA) G54MT8V18GHEPATITIS A VIRUSConfirmed FDA, Wikidata
- RxNorm 1491862One source FDA
- Wikidata Q4112120Hepatitis A virusConfirmed FDA, Wikidata
- NCI Thesaurus C14325Hepatitis A VirusOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | G54MT8V18G | HEPATITIS A VIRUS | Confirmed FDA, Wikidata |
| RxNorm | 1491862 | — | One source FDA |
| Wikidata | Q4112120 | Hepatitis A virus | Confirmed FDA, Wikidata |
| NCI Thesaurus | C14325 | Hepatitis A Virus | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.